dockets: FDA-2004-P-0282

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id title docket_type last_modified object_id
FDA-2004-P-0282 FDA Declare that Glipizide and Metformin Hydrochloride Oral Solution, 2.5 mg/250 mg per 5 mL; 2.5 mg/500 mg per 10 mL and 5 mg/500 mg per 10 mL is suitable for submission as an ANDA-CLOSED Nonrulemaking 2021-09-01T01:02:16Z 0b000064804726d5

Links from other tables